ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

De ANI Pharmaceuticals, Inc. (ANIP) aandelenkoers vandaag is , wat een NaN% beweging weergeeft sinds de markt geopend. De marktkapitalisatie van het bedrijf staat op $ 1,69 mld., met een dagelijks tradevolume van aandelen. De vorige slotkoers was .

Klaar om aan de slag te gaan? Volg de onderstaande stappen, of lees onze gids over hoe je ANI Pharmaceuticals aandelen op Kraken kunt kopen vanaf € 10.